Yohei Hisada

Yohei Hisada, PhD is an Assistant Professor of Medicine in the Division of Hematology at the University of North Carolina at Chapel Hill School of Medicine. His research program focuses on the intersection of cancer biology and hemostasis, with particular emphasis on understanding the mechanisms behind cancer-associated thrombosis.

Dr. Hisada's research interests center on the complex relationship between malignancy and coagulation disorders. His laboratory investigates how pancreatic cancer specifically promotes venous thrombosis through multiple pathways including circulating tumor cells, extracellular vesicles, and inflammatory processes. His work has established important connections between tumor biology and thrombotic complications in cancer patients.

Analysis of Dr. Hisada's publication record from 2017-2024 reveals a consistent focus on cancer-associated thrombosis mechanisms. His research spans from fundamental molecular mechanisms to potential clinical applications, with a notable emphasis on pancreatic cancer-related venous thrombosis. His work frequently explores the role of tissue factor, extracellular vesicles, and inflammatory pathways in promoting thrombosis in cancer patients.

Dr. Hisada maintains a productive collaboration with Dr. Nigel Mackman, with whom he has co-authored the majority of his publications. His research program appears to be well-funded, as evidenced by consistent publication output across multiple high-impact hematology and oncology journals. His laboratory likely utilizes both in vitro models and mouse models of cancer-associated thrombosis to investigate these complex mechanisms.

Dr. Hisada's laboratory likely focuses on translational aspects of cancer-associated thrombosis, with the goal of identifying biomarkers for risk stratification and developing targeted approaches to prevent or treat thrombotic complications in cancer patients, particularly those with pancreatic malignancies.